E-LIB Suche - Ergebnisse für: Crofoot, Gordon

1

Safety of teropavimab and zinlirvimab with lenacapavir once..:

Eron, Joseph J ; Little, Susan J ; Crofoot, Gordon...
The Lancet HIV. 11 (2024) 3 - p. e146-e155 , 2024

Link: https://doi.org/10.1016/..

2

Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in..:

Huhn, Gregory D ; Crofoot, Gordon ; Ramgopal, Moti...
Clinical Infectious Diseases. 71 (2019) 12 - p. 3110-3117 , 2019

Link: https://doi.org/10.1093/..

3

887. High Rates of Virologic Suppression Achieved in HIV-1–..:

Huhn, Gregory D ; Ramgopal, Moti ; Crofoot, Gordon...
Open Forum Infectious Diseases. 6 (2019) Supplement_2 - p. S21-S21 , 2019

Link: https://doi.org/10.1093/..

4

318. Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil F..:

DeJesus, Edwin ; Federico Andrade Villanueva, Jaime ; Ramon Arribas Lopez, Jose...
Open Forum Infectious Diseases. 6 (2019) Supplement_2 - p. S168-S169 , 2019

Link: https://doi.org/10.1093/..

5

1962. Renal Outcomes for Participants Taking F/TAF vs. F/TD..:

Mills, Anthony ; Workowski, Kimberly ; Campbell, Thomas...
Open Forum Infectious Diseases. 6 (2019) Supplement_2 - p. S64-S64 , 2019

Link: https://doi.org/10.1093/..

6

A Randomized Trial of Bictegravir or Dolutegravir with Emtr..:

Sax, Paul E ; Dejesus, Edwin ; Crofoot, Gordon...
Open Forum Infectious Diseases. 4 (2017) suppl_1 - p. S426-S427 , 2017

Link: https://doi.org/10.1093/..

7

Phase 3 Randomized, Controlled Trial of Switching to Fixed-..:

Daar, Eric ; DeJesus, Edwin ; Ruane, Peter...
Open Forum Infectious Diseases. 4 (2017) suppl_1 - p. S735-S735 , 2017

Link: https://doi.org/10.1093/..

8

Brief Report: Efficacy and Safety of Switching to a Single-..:

Gallant, Joel ; Brunetta, Jason ; Crofoot, Gordon...
JAIDS Journal of Acquired Immune Deficiency Syndromes. 73 (2016) 3 - p. 294-298 , 2016

Link: https://doi.org/10.1097/..

9

Efficacy and Safety of Tenofovir Alafenamide Versus Tenofov..:

Daar, Eric S. ; Gallant, Joel ; Crofoot, Gordon...
Open Forum Infectious Diseases. 3 (2016) suppl_1 - p. , 2016

Link: https://doi.org/10.1093/..

10

P029: Safety of tenofovir alafenamide in renal impairment:

Andrade-Villanueva, Jaime ; Pozniak, Anton ; Arribas, Jose...
Journal of the International AIDS Society. 18 (2015) 3 (Suppl 2) - p. , 2015

Link: https://doi.org/10.7448/..

11

P031: Tenofovir alafenamide in a single-tablet regimen in i..:

DeJesus, Edwin ; Wohl, David ; Pozniak, Anton...
Journal of the International AIDS Society. 18 (2015) 3 (Suppl 2) - p. , 2015

Link: https://doi.org/10.7448/..

12

Switching from a Tenofovir Disoproxil Fumarate (TDF) to a T..:

Thompson, Melanie ; Morales-Ramirez, Javier ; Mcdonald, Cheryl...
Open Forum Infectious Diseases. 2 (2015) suppl_1 - p. , 2015

Link: https://doi.org/10.1093/..

13

Phase IIIb, open‐label single‐arm trial of darunavir/cobici..:

Tashima, Karen ; Crofoot, Gordon ; Tomaka, Frank L...
Journal of the International AIDS Society. 17 (2014) 4S3 - p. , 2014

Link: https://doi.org/10.7448/..

14

Cobicistat-boosted darunavir in HIV-1-infected adults: week..:

Tashima, Karen ; Crofoot, Gordon ; Tomaka, Frank L...
AIDS Research and Therapy. 11 (2014) 1 - p. 39 , 2014

Link: https://doi.org/10.1186/..

15

Pharmacokinetics of Liposomal Nystatin in Patients with Hum..:

Rios, Adan ; Rosenblum, Michael ; Crofoot, Gordon...
The Journal of Infectious Diseases. 168 (1993) 1 - p. 253-254 , 1993

Link: https://www.jstor.org/st..